Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Yamamoto N, Oda M, Nishino T, Zhang M, Matsuo K, Wakasugi-Sato N, Matsumoto-Takeda S, Seta Y, Yoshiga D, Kaneuji T, Nogami S, Yoshioka I, Yamashita Y, Tanaka T, Miyamoto I, Kitamura C, Tominaga K, Morimoto Y. Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers.
Dentomaxillofac Radiol 2013;
42:20130014. [PMID:
23610089 DOI:
10.1259/dmfr.20130014]
[Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVES
To elucidate the points that require attention when interpreting fluorine-18-labelled fluoro-2-deoxy-d-glucose ((18)F-FDG)/positron emission tomography (PET) images by demonstration of (18)F-FDG accumulation in various areas of the oral cavity other than primary lesions in patients with oral cancers.
METHODS
(18)F-FDG accumulations with a maximal standardized uptake value of over 2.5 in various areas of the oral cavity other than primary lesions were identified in 82 patients with oral cancers.
RESULTS
(18)F-FDG/PET-positive areas, excluding primary tumours, included the front intrinsic muscles of the tongue (89.0%), upper and lower marginal parts of the orbicularis oris muscle (64.6%), sublingual glands, palatine tonsil, pharyngeal tonsil, and lingual tonsil. In addition, some areas in the jaws also showed accumulation.
CONCLUSIONS
In patients with oral cancers, areas of (18)F-FDG accumulation in the oral cavity should be precisely identified and appropriately diagnosed, because accumulations can be seen in areas other than the primary tumour.
Collapse